Medicinova Inc Share Price
MNOVMedicinova Inc Stock Performance
Open $1.54 | Prev. Close $1.54 | Circuit Range N/A |
Day Range $1.54 - $1.54 | Year Range $1.13 - $1.96 | Volume 100 |
Average Traded $1.54 |
Medicinova Inc Share Price Chart
About Medicinova Inc
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Medicinova Inc Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
25-Feb-26 | $1.48 | $1.49 | +9.56% |
24-Feb-26 | $1.48 | $1.36 | -8.72% |
23-Feb-26 | $1.48 | $1.49 | +1.36% |
20-Feb-26 | $1.54 | $1.47 | -6.67% |
18-Feb-26 | $1.60 | $1.57 | -1.87% |
17-Feb-26 | $1.60 | $1.60 | +6.64% |
13-Feb-26 | $1.52 | $1.50 | -3.83% |